article thumbnail

Biopharma could reap benefits from SVB UK acquisition

European Pharmaceutical Review

Impact of SVB UK acquisition on European biopharma companies One Netherlands-based biopharmaceutical company anticipated that the acquisition of SVP UK would allow access to its $19 million deposit and not experience losses, noted GlobalData.

article thumbnail

Connect With More Than 100 Healthcare Startups at MedCity INVEST 2024!

MedCity News

Equal parts networking and curated panels covering the latest trends in healthcare investment, MedCity INVEST 2024 is the ideal event to discuss health tech, biopharma, devices and diagnostics investment opportunities. Register today!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cultural agility: the key to building trust with biopharma partners

Pharmaceutical Technology

Working in an industry with regular cross-border manufacturing and dealing with a global network of clients means adaptability is vital to maintaining good communications, building relationships, and managing teams effectively.

article thumbnail

Fujifilm plans $1.2 billion investment in major US manufacturing facility

European Pharmaceutical Review

Significant” large-scale production capacity will consequently be added to FUJIFILM Diosynth Biotechnologies’ global network. The expansion means identical large-scale production facilities can be built in US and Europe to support integration drug manufacturing production “regardless of location”, FUJIFILM explained.

article thumbnail

Sandoz mobilises critical medicine production in Europe

European Pharmaceutical Review

Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. Launch of these new facilities help to ensure sustainable access to quality antibiotics and spearhead development of biosimilars, Sandoz noted.

article thumbnail

FUJIFILM Diosynth recruits new Quality leader

European Pharmaceutical Review

With 20 years of leadership experience in the life sciences and biopharma sector, Pedersen has previously had senior leadership positions in quality assurance (QA) and quality control ( QC ), regulatory affairs as well as external manufacturing. “She There, she oversaw the entire CDMO network.

article thumbnail

Sandoz to boost biosimilar development with manufacturing expansion

European Pharmaceutical Review

The company intends to grow its Biopharma Technical Development (BioTD) capabilities and transform the lab building into a state-of-the-art biotech lab by the last quarter of 2023. Sandoz has announced it is investing €25 million in its manufacturing site in Holzkirchen, Germany, to expand its biosimilar development capabilities.